| Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA KH Asrani, JD Farelli, MR Stahley, RL Miller, CJ Cheng, RR Subramanian, ... RNA biology 15 (6), 756-762, 2018 | 113 | 2018 |
| G6PC mRNA therapy positively regulates fasting blood glucose and decreases liver abnormalities in a mouse model of glycogen storage disease 1a DS Roseman, T Khan, F Rajas, LS Jun, KH Asrani, C Isaacs, JD Farelli, ... Molecular Therapy 26 (3), 814-821, 2018 | 70 | 2018 |
| SERPINA1 mRNA as a treatment for Alpha‐1 antitrypsin deficiency B Connolly, C Isaacs, L Cheng, KH Asrani, RR Subramanian Journal of nucleic acids 2018 (1), 8247935, 2018 | 50 | 2018 |
| Arginase I mRNA therapy–a novel approach to rescue arginase 1 enzyme deficiency KH Asrani, L Cheng, CJ Cheng, RR Subramanian RNA biology 15 (7), 914-922, 2018 | 38 | 2018 |
| Herbal drugs in chronic fatigue syndrome: an overview A Semalty, M Semalty, VS Panda, KH Asrani, HD Ashar Schweizerische Zeitschrift für Ganzheitsmedizin/Swiss Journal of Integrative …, 2012 | 12 | 2012 |
| Leveraging Rational Protein Engineering to Improve mRNA Therapeutics JD Farelli, KH Asrani, C Isaacs, JS deBear, MR Stahley, A Shah, ... Nucleic Acid Therapy, 2018 | 10 | 2018 |
| Innate and adaptive immunity in cancer AS Doshi, KH Asrani Cancer Immunology and Immunotherapy, 19-61, 2022 | 2 | 2022 |
